Good morning ... Come on, folks. Be better than disorderly conduct at a Cheesecake Factory.
Illustration: Aïda Amer/Axios
The next wave of state actions to combat the opioid crisis may focus on taxing prescription painkillers, my colleague Caitlin Owens reports this morning.
The other side: Opponents, including the pharmaceutical industry, say these taxes could make it harder for people to get the pain medication they need.
What to watch: Oral arguments in the New York suits are scheduled for Monday.
Public health officials — including some state and local governments — want a lot of people to be carrying naloxone, so that they can easily help save a life if they see someone who has overdosed on opioids.
"We want naloxone to be available to a wide group of people, people who have an opioid use disorder themselves but also [those in] their social networks and other people in a position to rescue them," Alex Walley, a doctor who works on Massachusetts' anti-opioids initiative, told Boston's WBUR.
WBUR found multiple people who had been denied life insurance because of a naloxone prescription, including a nurse who does not use opioids but participated in a state program that involves standing prescriptions for health care professionals to fill.
AbbVie spent billions of dollars to acquire a potential cancer drug known as Rova-T, but the drug is looking more and more like a bad investment, Business Insider reports.
Details: AbbVie has stopped enrolling new patients in a Phase 3 clinical trial for Rova-T, which an outside monitoring committee had recommended.
Among the hallmarks of 2018 are news items that present as feel-good stories unless you think about them for more than 15 seconds, in which case they become vividly apparent as feel-bad stories. Here’s one of them, from the New York Times.
Two women in New York state have helped pay off medical debt for nearly 13,000 people, through a charity called R.I.P. Medical Debt.
Yes, but: “It is a drop in the bucket,” Craig Antico, one of the charity’s founders, told NYT.
Most people haven’t gotten a flu shot yet, and 41% say they don’t intend to, according to a new survey from NORC at the University of Chicago.